CDEK
by
Data4ThePeople
Drugs
Organizations
Indications
Mechanisms
Trials
FDA Approvals
About
Sign in
Sign up
Drugs
Organizations
Indications
Mechanisms
Trials
FDA Approvals
About
← All organizations
ORIG3N
For profit
Website ↗
Phase 1
Phase 2
Phase 3
Phase 4
Timeline
Org Milestones
All Trials
Drug Relationships
2010s
Apr 10, 2014
ORIG3N
— Founded
Nov 22, 2017
Interleukin Genetics
— Acquired
Drugs by trial phase
(4 distinct, 1 trials)
Other trials
(0 own, 4 via acquisition)
rose hips extract
aframomum melegueta extract
blueberry/blackberry extract
reseveravine
Subsidiaries
(1 direct, 1 total across the full acquisition tree)
Interleukin Genetics
Details
Founded
Boston, MA, US
Apr 10, 2014